New nebulizer may ease chronic sinusitis symptoms
NCT ID NCT07270302
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests if a nebulized steroid (budesonide) delivered via the NasoNeb device is safe and effective for chronic rhinosinusitis. 50 adults with the condition will be randomly assigned to receive either nebulized budesonide or a standard steroid lavage. The main goal is to see if the nebulized version improves symptoms more, as measured by a sinus symptom questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
budesonide
What this could lead to
If successful, this could offer a more effective way to deliver steroids to the sinuses, improving symptoms like congestion and facial pain.
What could go wrong
This is an early Phase 1/2 trial with only 50 participants, so results may not apply widely. The treatment may not work better than standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nyssa Fox Farrell
St Louis, Missouri, 63122, United States